Clemens Richter

3.2k total citations · 1 hit paper
62 papers, 2.1k citations indexed

About

Clemens Richter is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Clemens Richter has authored 62 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 22 papers in Epidemiology and 16 papers in Hepatology. Recurrent topics in Clemens Richter's work include HIV/AIDS drug development and treatment (26 papers), Hepatitis C virus research (16 papers) and HIV/AIDS Research and Interventions (15 papers). Clemens Richter is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), Hepatitis C virus research (16 papers) and HIV/AIDS Research and Interventions (15 papers). Clemens Richter collaborates with scholars based in Netherlands, Tanzania and United States. Clemens Richter's co-authors include Peter Reiss, Elizabeth H. Gisolf, Nienke Langebeek, Pythia T. Nieuwkerk, Thóra B. Hafsteinsdøttir, Mirjam A. G. Sprangers, Sigrid C. J. M. Vervoort, Frank P. Kroon, David M. Burger and Paul F. M. Krabbe and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Clemens Richter

61 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis

2014 307 citations Nienke Langebeek, Elizabeth H. Gisolf et al. BMC Medicine profile →

Peers

Countries citing papers authored by Clemens Richter

Since Specialization

Citations

This map shows the geographic impact of Clemens Richter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clemens Richter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clemens Richter more than expected).

Fields of papers citing papers by Clemens Richter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clemens Richter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clemens Richter. The network helps show where Clemens Richter may publish in the future.

Co-authorship network of co-authors of Clemens Richter

This figure shows the co-authorship network connecting the top 25 collaborators of Clemens Richter. A scholar is included among the top collaborators of Clemens Richter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clemens Richter. Clemens Richter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients. 2016 ·Data Archiving and Networked Services (DANS) ·Tom J.G. Gevers, David M. Burger, (unknown), M. P. Kooistra, Clemens Richter	9
2	Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients 2015 ·Journal of Hepatology ·Sebastiaan Hullegie, Mark A. A. Claassen, Guido E.L. van den Berk, Jan T. M. van der Meer, Dirk Posthouwer, Fanny N. Lauw, Eliane M.S. Leyten, Peter P. Koopmans, Clemens Richter, Arne van Eeden, Wouter F.W. Bierman, Astrid M. Newsum, Joop E. Arends, Bart Rijnders	16
3	Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis breakdown → 2014 ·BMC Medicine ·Nienke Langebeek, Elizabeth H. Gisolf, Peter Reiss, Sigrid C. J. M. Vervoort, Thóra B. Hafsteinsdøttir, Clemens Richter, Mirjam A. G. Sprangers, Pythia T. Nieuwkerk	307
4	Real-life costs of hepatitis C treatment. 2012 ·PubMed ·Charles W. Helsper, (unknown), Gerrit A. van Essen, G. Ardine de Wit, (unknown), Karel J. van Erpecum, A. I. M. Hoepelman, Clemens Richter, (unknown)	11
5	Treatment of Calcium and Vitamin D Deficiency in HIV-Positive Men on Tenofovir-Containing Antiretrovial Therapy 2012 ·HIV Clinical Trials ·Anneke Bech, Petra van Bentum, Darryl Telting, (unknown), Clemens Richter, Hans de Boer	14
6	Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus 2010 ·Gastroenterology ·T.E.M.S. de Vries-Sluijs, Jurriën G.P. Reijnders, Bettina E. Hansen, Hans L. Zaaijer, Jan M. Prins, Suzan D. Pas, Martin Schutten, Andy I. M. Hoepelman, Clemens Richter, Jan W. Mulder, Rob A. de Man, Harry L.A. Janssen, Marc van der Valk	85
7	Abacavir/Lamivudine/Zidovudine Maintenance After Standard Induction in Antiretroviral Therapy-Naïve Patients: FREE Randomized Trial Interim Results 2010 ·AIDS Patient Care and STDs ·Herman G. Sprenger, (unknown), Paul Mulder, Chris H.H. ten Napel, (unknown), Andy I. M. Hoepelman, (unknown), Peter P. Koopmans, M.E.E. van Kasteren, Bert Bravenboer, Reinier W. ten Kate, P. H. P. Groeneveld, Tjip S. van der Werf, Elisabeth H. Gisolf, Clemens Richter	4
8	Lymphomatoide Granulomatose - Remissionsinduktion mit lnterferon-α_2b 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Clemens Richter, A. Schnabel, K.-M. Müller, M. Reuter, Paul Schuster, Wolfgang L. Gross	4
9	A Prospective Multicenter Study on Fever of Unknown Origin 2007 ·Medicine ·Chantal P. Bleeker‐Rovers, Fidel J. Vos, Elisabeth M. H. A. de Kleijn, Aart Mudde, (unknown), Clemens Richter, Tineke J. Smilde, Paul F. M. Krabbe, Wim J.G. Oyen, J.W.M. van der Meer	264
10	Extrapulmonary Tuberculosis by Nationality, the Netherlands, 1993–2001 2006 ·Emerging infectious diseases ·(unknown), Marieke J. van der Werf, Clemens Richter, Martien W. Borgdorff	94
11	Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naive adults 2005 ·Clinical Trials ·(unknown), Amj Wensing, (unknown), (unknown), Clemens Richter, Gerrit Schreij, Petra C. Koopmans, (unknown), Ingeborg van der Tweel, J Lange, Jan C.C. Borleffs	3
12	Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals 2003 ·AIDS ·David M. Burger, Patricia W. H. Hugen, Peter Reiss, Inge C. Gyssens, M. M. E. Schneider, Frank P. Kroon, Gerrit Schreij, Kees Brinkman, Clemens Richter, Jan M. Prins, Rob E. Aarnoutse, Joep M. A. Lange	119
13	[Immunodeficiency in adult patients as the first sign of a primary underlying condition]. 2003 ·Data Archiving and Networked Services (DANS) ·Jurgen A.H.R. Claassen, R. A. de Vries, Clemens Richter	1
14	Replacing ritonavir by nelfinavir or nelfinavir/saquinavir as part of highly active antiretroviral therapy leads to an improvement of triglyceride levels 2001 ·AIDS ·Annemarie M. J. Wensing, (unknown), Clemens Richter, Charles A. Boucher, Jan C.C. Borleffs	14
15	The ADAM study continued: maintenance therapy after 50 weeks of induction therapy 2001 ·AIDS ·Monique H. Reijers, Gerrit Jan Weverling, Suzanne Jurriaans, Marijke Roos, Ferdinand W N M Wit, Hugo M. Weigel, Reinier W. ten Kate, Jan W. Mulder, Clemens Richter, (unknown), Herman G. Sprenger, Richard M. W. Hoetelmans, Hanneke Schuitemaker, Joep M. A. Lange	5
16	PCR detection of Mycobacteraemia in Tanzanian patients with extrapulmonary tuberculosis 1996 ·European Journal of Clinical Microbiology & Infectious Diseases ·Clemens Richter, L. F. F. Kox, J. van Leeuwen, Isaac Mtoni, A H Kolk	14
17	Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis 1995 ·Tubercle and Lung Disease ·Clemens Richter, (unknown), A.B.M. Swai, R.M. Perenboom, D H Mwakyusa, Jan Oosting	16
18	Clinical features of HIV seropositive and HIV seronegative patients with tuberculous lymphadenitis in Dar es Salaam 1995 ·Tubercle and Lung Disease ·R.M. Perenboom, Clemens Richter, A.B.M. Swai, James Kitinya, Isaac Mtoni, (unknown), (unknown)	12
19	Chest radiography and beta-2-microglobulin levels in HIV-seronegative and HIV-seropositive African patients with pulmonary tuberculosis. 1994 ·PubMed ·Clemens Richter, Kisali Pallangyo, (unknown), H. J. Chum, A.B.M. Swai, (unknown)	8
20	Extrapulmonary tuberculosis--a simple diagnosis? A retrospective study at Dar es Salaam, Tanzania. 1991 ·PubMed ·Clemens Richter, (unknown), (unknown), (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact